喘中的生物学和气道改造:早期,晚期和潜在的预防作用
G Varricchi1,2,3,4, R Poto1,2,3, M Lommatzsch5
1Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Allergy
|November 9, 2024
概括
生物药物可以在严重的喘中逆转气道重塑,与葡萄糖皮质激素不同. 需要进一步的研究来了解生物治疗对喘的早期,晚期和预防性影响.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在严重的喘中,呼吸道重塑通常被认为是不可逆转的,对症状和肺功能下降的贡献尚不清楚.
- 吸入的葡萄皮质类药物在逆转气道改造方面表现出有限的有效性.
- 针对特定炎症途径的生物药物在肺功能和呼吸道结构方面表现出优异的改善,与葡萄糖皮质体相比.
研究的目的:
- 提出一种基于时间效应的生物影响对呼吸道改造的新分类:早期,晚期和预防性.
- 突出需要进一步探索生物治疗优于葡萄糖皮质激素的必要性.
- 呼吁开展研究,研究早期生物干预对中度至重度喘的长期预防作用.
主要方法:
- 文献综述和对呼吸道改造和生物疗法现有数据的综合.
- 关于生物效应 (早期,晚期,预防性) 的时间分类框架的建议.
- 对未来的研究设计进行概念化,以评估预防性影响.
主要成果:
- 生物药物显示有潜力改善肺功能,粘液堵塞和空气道结构变化,超出葡萄糖皮质体效应.
- 为了解生物影响,提出了三层时间分类 (早期,晚期,预防性).
- 早期的生物治疗可能会对呼吸道改造产生预防作用.
结论:
- 生物药物代表了一种有前途的治疗策略,用于治疗严重喘的呼吸道改造.
- 进一步的研究对于阐明生物制剂的机制和长期益处至关重要,特别是其预防潜力.
- 评估临床,生物标志物和社会经济结果的长期研究对于优化生物治疗至关重要.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234
01:20Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:19Antiasthma Drugs: Leukotriene Modifiers
245
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
245